RELATED STUDY

Pharmacology, Clinical Effects, and Therapeutic Potential of Cannabinoids for Gastrointestinal and Liver Diseases

Key Findings:  the authors posit that cannabinoids (e.g. 2-AG, Anandamide, CBD, THC) can cause hyperemesis and cyclic vomiting syndrome on one hand, but may also reduce gastrointestinal, pancreatic, or hepatic inflammation, as well as a treatment for motility, abdominal pain, and functional abdominal disorders.

Type of Study:  Meta-analysis

Study Result:  Inconclusive

Study Location(s):  United States

Year of Pub:  2021


Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC), Anandamide (AEA), Fatty Acid Amide Hydrolase (FAAH), 2-Arachidonoyl Glycerol (2-AG), Monoacylglycerol Lipase (MAGL)

Phytocannabinoid Source:  Unspecified